IFCC Feed2021-04-12T20:02:15Z Insoft Feed Generator /ifcc-news/ IFCC Live Webinar 6th April: soon available on demand2021-04-07T13:58:55Z /ifcc-news/2021-04-06-on-demand-content-soon-available-application-of-laboratory-techniques-in-the-diagnosis-of-infectious-diseases-translation-in-chinese-1/ IFCC Office

实验室技术在感染性疾病诊断中的应用

6th April, 2021
Today's IFCC webinar content

will be soon available on demand!

Registration link is

https://www.workcast.com/register?cpak=8172916142437123

Simultaneous translation in Chinese

Dear Colleagues,

Next IFCC webinar on “Application of laboratory techniques in the diagnosis of Infectious Diseases” will be held on April 6, 2021. Infectious diseases are one of the most intimidating threats, responsible for an immense burden of disabilities and deaths. Identification of pathogens through rapid, specific, sensitive, and cost-effective diagnostic tools is key for successful therapeutic interventions. This webinar will focus on recent laboratory techniques including metagenomic Next‐Generation Sequencing (mNGS) and digital PCR in the diagnosis of infectious diseases.

Please ensure you register to attend the live event and have access to the on demand content and to the certificate.

Registration link is:

https://www.workcast.com/register?cpak=8172916142437123

  • Schedule: 20 min per speaker plus 20 min panel discussion
  • Time Zones: Live presentations starting at 7:30 PM Beijing Time; 7:30 AM Eastern Time US; 1:30 PM European Time
    Important: Please ensure that you carefully determine the time that the presentation will start in your global time zone. To calculate this, you can use the time zone converter tool at: www.timeanddate.com/worldclock/converter.html.
  • Recorded webinar: available on demand
  • Certificate of Participation: available for all registrants 

 

]]>
IFCC eNews No 4 April 20212021-04-02T19:33:14Z /ifcc-news/2021-04-01-ifcc-enews-no-4-april-2021/ IFCC Office  

 


IFCC eNews: April 2021

eNews logo large globe
Full PDF version

IN THIS ISSUE:

  • EDITORIAL
    • Message from the eNews editor
  • THE VOICE OF IFCC
    • Message from the IFCC President - April 2021
    • Register for the next IFCC webinar!

  • IFCC: PEOPLE
    • IFCC call for nominations

  • IFCC: THE YOUNG SCIENTISTS
    • Mentorship interview

  • CONTRIBUTE TO IFCC eNEWS
    • The Top 10 “Count-Ups” to Healthcare Excellence at Biomédica de Referencia (Mexico)

    • Vaccination: the way out!

    • Sheila – unlocking the treatment for PKU

  • NEWS FROM REGIONAL FEDERATIONS AND MEMBER SOCIETIES
    • Malawi Association of Medical Laboratory Scientists (MAMLS): Accreditation of the first four laboratories in Malawi

    • News from the Spanish Society of Laboratory Medicine (SEQCML)

    • News from the Japan Society of Clinical Chemistry (JSCC)

    • EFLM Courses

    • Tackling the pandemic crisis in Overseas France

  • IFCC'S CALENDAR OF CONGRESSES, CONFERENCES
    • Calendar of IFCC Congresses/Conferences and Regional Federations' Congresses

    • Calendar of events with IFCC auspices

]]>
DIAGNÓSTICO in VITRO February Issue: New Format & Improved Readability!2021-03-27T08:57:55Z /ifcc-news/2021-02-28-div-february-2021/ IFCC Office Auspiciado por la Federación Internacional de Química Clínica, "Diagnóstico in Vitro" es un nexo de unión entre los países Latinoamericanos, Portugal y España, que contribuye a difundir temas científicos a través de Internet, facilitando el conocimiento de publicaciones y temas de interés comunes a las ciencias del laboratorio clínico.

 

Número Febrero 2021

Cover PDF.jpg Cover Flip.jpg

Click here to access the PDF version
Clic aquí para acceder la versión PDF

Click here to access the Flip version
Clic aquí para acceder la versión Flip

 

EDITORIAL
NOVEDADES Y NOTICIAS
ARTÍCULOS CIENTÍFICOS
CARTAS AL EDITOR
REPORTAJE

 

]]>
IFCC Information Guide on COVID-19 - 22 March 2021 Updates2021-03-23T05:33:42Z /ifcc-news/2021-03-22-ifcc-information-guide-on-covid-19/ IFCC Office  

 

 

IFCC Information Guide on COVID-19

Click aquí para descargar el Resumen traducido de la Guía de Información de la IFCC sobre COVID-19
Kliknutím zde stáhnete českou verzi IFCC informačního  souhrnu o COVID 19 z 16 . dubna 2020

 

 

 

 

Coronavirus disease 2019, abbreviated to COVID-19, is an emerging global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As the number of individuals infected with COVID-19 continues to rise globally and healthcare systems become increasingly stressed, it is clear that the clinical laboratory will play an essential role in this crisis, contributing to patient screening, diagnosis, monitoring/treatment, as well as epidemiologic recovery/surveillance. This guide aims to organize relevant available information on laboratory screening, testing protocols, diagnosis, and other general information on COVID-19 for laboratory professionals, including links to helpful resources and interim guidelines. It will be continually updated as new guidelines and literature become available.

 

Click here to access to the different chapters of the IFCC Guide 

 


 

 

Table of Contents:

  1. General Information
  2. Patient Screening
  3. Diagnostic Testing
  4. Biosafety Guidelines for the Clinical Laboratory
  5. Biochemical Monitoring of COVID-19 Patients
  6. Other Educational Materials & Webinars
  7. Big Data Tools
  8. New SECTION on Vaccination: Considerations for the Clinical Laboratory

_____________________________________________________________________

]]>
Save the date for the IFCC Live Webinar 6th April: Application of laboratory techniques in the diagnosis of Infectious Diseases - 实验室技术在感染性疾病诊断中的应用2021-03-18T13:20:02Z /ifcc-news/2021-03-16-save-the-date-ifcc-live-webinar/ IFCC Office

6th April, 2021
Mark on your agenda next IFCC webinar!

Don’t miss it!

Registration link soon available

Simultaneous translation in Chinese

Infectious diseases are one of the most intimidating threats, responsible for an immense burden of disabilities and deaths. Identification of pathogens through rapid, specific, sensitive, and cost-effective diagnostic tools is key for successful therapeutic interventions. This webinar will focus on recent laboratory techniques including metagenomic Next‐Generation Sequencing (mNGS) and digital PCR in the diagnosis of infectious diseases.

Please ensure you register to attend the live event and have access to the recording and to the certificate.

Registration link soon available!

  • Schedule: 20 min per speaker plus 20 min panel discussion
  • Time Zones: Live presentations starting at 7:30 PM Beijing Time; 7:30 AM Eastern Time US; 1:30 PM European Time
    Important: Please ensure that you carefully determine the time that the presentation will start in your global time zone. To calculate this, you can use the time zone converter tool at: www.timeanddate.com/worldclock/converter.html.
  • Recorded webinar: available on demand
  • Certificate of Participation: available for all registrants 
]]>
Call for Nominations2021-03-18T13:19:46Z /ifcc-news/2021-03-15-ifcc-call-for-nominations/ IFCC Office  

=================

Emerging Technologies Division

  • Committee on Omics Translation (C-OT): one Corporate member position - time in office 2021-2023.
    Deadline to receive nominations and supporting documents: 15th April 2021.

=================

Applications for these positions should be submitted by IFCC members (National Societies or Corporate members). If you are interested, please refer to your National Representative or Corporate Representative for information on procedures for nominations. Find your representative HERE

For further information on the open Calls for Nominations, please visit the IFCC Call for Nominations page.

=================

]]>
Joint IFCC WorldLab and APFCB Congress in June 20222021-03-09T12:30:06Z /ifcc-news/2021-03-09-joint-ifcc-worldlab-and-apfcb-congress-in-june-2022/ IFCC Office  

 

Dear Colleagues,

We are pleased to inform you that the 24th WorldLab Congress in Seoul will be held jointly with the 16th APFCB (Asia-Pacific Federation of Clinical Biochemistry) Congress in June 2022.

 

The IFCC and APFCB have agreed that a joint conference would be more attractive and beneficial for both conference delegates and corporate sponsors and will ensure wider participation from laboratory professionals and industry partners across Asia-Pacific and around the world.

 

The host Society, the Korean Society for Clinical Chemistry (KSCC) has also very graciously agreed to host the joint WorldLab-APFCB Congress in Seoul which has also been approved by the IFCC and APFCB Executive Boards.

The Joint WorldLab-APFCB Congress will be held on 26th -30th June 2022 in Seoul at the Coex Convention and Exhibition Center.

We welcome all IFCC national societies and corporate members to actively participate in this major and exciting event next year.

 

Yours sincerely

Prof. Khosrow Adeli

IFCC President

]]>
IFCC eNews No 3 March 20212021-03-09T12:30:03Z /ifcc-news/2021-03-08-ifcc-enews-no-3-march-2021/ IFCC Office  

 


IFCC eNews: March 2021

eNews logo large globe
Full PDF version

IN THIS ISSUE:

  • EDITORIAL
    • Message from the eNews editor
  • THE VOICE OF IFCC
    • Message from the IFCC President - March 2020
    • The new IFCC Task Force on Global Newborn Screening (TF-NBS)

    • The IFCC Task Force of Corporate Members (TF-CM) unite with a passion to elevate laboratory medicine and the IFCC

    • Introducing the IFCC Working Group on Artificial Intelligence and Genomic Diagnostics (WG-AIGD)

    • A report on IFCC Webinars Live Series Fall 2020

  • IFCC: PEOPLE
    • Welcome and thanks to the Chairs
    •  Never forgotten – in memory of Professor Nils Tryding

    • IFCC call for nominations

  • IFCC: THE YOUNG SCIENTISTS
    • COLABIOCLI Leadership Workshop

  • CONTRIBUTE TO IFCC eNEWS
    • Improving patient safety in patients with Indeterminant Pulmonary Nodules: an integrated clinical care team in China wins distinction

    • Reducing medical errors and enhancing patient care through strategic point-of-care testing led by laboratory medicine

    • Web App “Clinical Laboratory Diagnostics 2020” free of charge and ads

    • D-Dimers ELISA: predictor of gestational complications in women with antiphospholipid syndrome

  • NEWS FROM REGIONAL FEDERATIONS AND MEMBER SOCIETIES
    • The monograph Scientific Foundation “Professor Ivan Berkeš”

    • News from the Japan Society of Clinical Chemistry (JSCC)

    • Updates on EFLM publications

  • IFCC WELCOMES NEW CORPORATE MEMBERS
    • Shenzhen YHLO Biotech Co., Ltd

    • Technogenetics

    • Instrumentation Laboratory

    • PerkinElmer

  • IFCC'S CALENDAR OF CONGRESSES, CONFERENCES
    • Calendar of IFCC Congresses/Conferences and Regional Federations' Congresses

    • Calendar of events with IFCC auspices

]]>
IFCC Information Guide on COVID-19 - 3 March 2021 Updates2021-03-09T12:29:53Z /ifcc-news/2021-03-08-ifcc-information-guide-on-covid-19/ IFCC Office  

 

 

IFCC Information Guide on COVID-19

Click aquí para descargar el Resumen traducido de la Guía de Información de la IFCC sobre COVID-19
Kliknutím zde stáhnete českou verzi IFCC informačního  souhrnu o COVID 19 z 16 . dubna 2020

 

 

 

 

Coronavirus disease 2019, abbreviated to COVID-19, is an emerging global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As the number of individuals infected with COVID-19 continues to rise globally and healthcare systems become increasingly stressed, it is clear that the clinical laboratory will play an essential role in this crisis, contributing to patient screening, diagnosis, monitoring/treatment, as well as epidemiologic recovery/surveillance. This guide aims to organize relevant available information on laboratory screening, testing protocols, diagnosis, and other general information on COVID-19 for laboratory professionals, including links to helpful resources and interim guidelines. It will be continually updated as new guidelines and literature become available.

 

Click here to access to the different chapters of the IFCC Guide 

 


 

 

Table of Contents:

  1. General Information
  2. Patient Screening
  3. Diagnostic Testing
  4. Biosafety Guidelines for the Clinical Laboratory
  5. Biochemical Monitoring of COVID-19 Patients
  6. Other Educational Materials & Webinars
  7. Big Data Tools
  8. NEW SECTION Vaccination: Considerations for the Clinical Laboratory

_____________________________________________________________________

]]>
eJIFCC Vol 32 n° 12021-03-05T12:31:30Z /ifcc-news/2021-02-28-ejifcc-vol-32-n-1/ IFCC Office  

 

eJIFCC Volume 32 no 1 - 2021

In this issue: Measurably better healthcare
 
eJIFCC New 2015 Thumb for web.jpg
Click here to download a PDF of the full issue.
 
1 Foreword: Measurably better health care – signs of a (r)evolution in progress towards a new academic science?
Guest editors: Tim J. James, Ellie Dow
2 Laboratory medicine and healthcare excellence – till death do us part
Colleen Strain, Tricia H. Ravalico
3 Procalcitonin (PCT) level in the emergency department identifies a high-risk cohort for all patients treated for possible sepsis
Georgia Lucas, Angela Bartolf, Nicholas Kroll, Agampodi-Umanda De Thabrew, Zoya Murtaza, Siddarth Kumar, Abrar Gani, Andrea Annoni, Marie Parsons, Helen Pardoe
4 Reducing patient risk and enhancing care through the development and implementation of a new chest pain pathway, expedited by and for the COVID-19 era
Martin P. Than, John W. Pickering, Philip Adamson, Thomas Clendon, Christopher M. Florkowski, John Lainchbury, Jacques Loubser, Alison Nankivel, Sally J. Aldous
5 Avoiding insufficient therapies and overdosing with co-reporting eGFRs (estimated glomerular filtration rate) for personalized drug therapy and improved outcomes – a simulation of the financial benefits
Adrian Hoenle, Karin Johanna Haase, Sebastian Maus, Manfred Hofmann, Matthias Orth
6 The use of faecal haemoglobin in deciding which patients presenting to primary care require further investigation (and how quickly) – the FIT approach
Judith A. Strachan, Craig Mowat
7 The Kidney Check program – championing patient-centered, culturally safe, preventive kidney care in Canada’s rural and remote Indigenous communities
Sarah Curtis, David Collister, Heather Martin, Abdul Razaq Sokoro, Lorraine McLeod, Caroline Chartrand, Barry Lavallee, Cathy Woods, Adeera Levin, Paul Komenda
8 Is COVID-19 impacting prostate cancer screening? A survey of prostate-specific antigen test requests during a local outbreak
Anna Ferrari, Fabian Sanchis-Gomar, Camilla Mattiuzzi, Brandon M. Henry, Giuseppe Lippi
9 Monitoring of diabetic patients with poor glycemic control. Are international recommendations met?
José Antonio Delgado, Josep Miquel Bauça
10 Multicenter survey of physicians’ perception of interpretative commenting and reflective testing in Nigeria
Lucius Chidiebere Imoh, Chinelo Pamela Onyenekwu, Kenneth Ogar Inaku, Alexander Oghielu Abu, Chibuzo David Tagbo, Idris Yahaya Mohammed, Modupe Akinrele Kuti
11 E-gene RT-PCR crossing point value and other biochemical parameters as useful markers of death risk in COVID-19 patients
Alba Bellés-Bellés, María Bernal, Javier Gómez-Arbonés, Albert Bernet, Silvia Picó, Jessica Bueno, Carlos Chávez, Mercè García-González, Mercè Ibarz
12 Diabetic euglycemic ketoacidosis induced by oral antidiabetics type SGLT2i
Guillermo Velasco de Cos, María Isabel Sánchez-Molina Acosta, María Matilde Toval Fernández

 

]]>